Effects of Physical Treatment on Postural Stability in Benign Paroxysmal Positional Vertigo (BPPV) Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00978809|
Recruitment Status : Withdrawn (major difficulties recruiting patients)
First Posted : September 17, 2009
Last Update Posted : April 17, 2015
The propose of this study is to compare two methods of physical treatment for benign paroxysmal positional vertigo, by evaluating treatment effects on postural stability.
The trail design is a double blinded randomized controlled trail, with each patient going through three evaluations: before treatment, 1 week after treatment and 60 days after treatment.
|Condition or disease||Intervention/treatment||Phase|
|Benign Paroxysmal Positional Vertigo||Other: Epley maneuver Other: Semont maneuver||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Care Provider, Investigator)|
|Official Title:||Epley Maneuver vs. Semont Maneuver for Benign Paroxysmal Positional Vertigo (BPPV): Evaluating Treatment Effectiveness by Postural Stability - a Double Blinded Randomized Controlled Trial.|
|Study Start Date :||September 2009|
|Estimated Primary Completion Date :||June 2010|
|Actual Study Completion Date :||June 2010|
Active Comparator: Semont
BPPV patients treated by Semont maneuver by a physical therapist.
Other: Semont maneuver
Other Name: liberatory manoeuvre
No Intervention: control
Active Comparator: Epley maneuver
BPPV patients treated with Epley maneuver by a physical therapist.
Other: Epley maneuver
Other Name: canalith repositioning maneuver
- postural stability [ Time Frame: 60 days post treatment ]
- subjective vertigo [ Time Frame: 60 days post treatment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00978809
|Maccabi health services|
|Beer Sheva, Israel|
|Study Chair:||Itshak Melzer, Dr||Ben-Gurion University of the Negev|
|Study Director:||Moshe Puterman, Dr||Soroka University Medical Center|